This article was originally published here
BMJ Open Diabetes Res Care. 2021 May; 9 (1): e002033. doi: 10.1136 / bmjdrc-2020-002033.
ABSTRACT
INTRODUCTION: Bariatric and metabolic...
(Reuters) - The U.S. Food and Drug Administration on Tuesday rejected Prevention Bio Inc.'s approval of the experimental diabetes drug teplizumab, citing insufficient data,...